ArticleFrontiers in oncology2023

SARS-CoV-2 infection in high-risk children following tixagevimab-cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study.

Diego R Hijano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.